header logo image

Trading in Novo Nordisk shares by board members, executives and associated persons on 3-4 February 2021

February 7th, 2021 3:51 am

Bagsværd, Denmark, 5 February 2021 — This company announcement discloses the data of the transaction(s) made in Novo Nordisk shares by the company’s board members, executives and their associated persons in accordance with Article 19 of Regulation No. 596/2014 on market abuse.

See more here:
Trading in Novo Nordisk shares by board members, executives and associated persons on 3-4 February 2021

Related Post

Comments are closed.


2024 © StemCell Therapy is proudly powered by WordPress
Entries (RSS) Comments (RSS) | Violinesth by Patrick